Eatontown-based Hikma Pharmaceuticals USA Inc., a wholly-owned subsidiary of Hikma Pharmaceuticals PLC, announced it has appointed Kristy Ronco as executive vice president, sales and marketing for its Generics Division.
Ronco will be responsible for leading Generics’ retail sales, addiction therapy sales and branded sales teams. She will also oversee marketing, pricing, forecasting and analytics.
“Kristy is a talented leader with significant pharmaceutical industry experience across sales, marketing, operations, market analysis, contracts and pricing, and we are delighted she is joining our team,” Brian Hoffmann, president of Hikma’s Generics Division, said. “I am looking forward to working closely with Kristy and her team to deliver substantial value to our customers, employees and the broader communities we serve.”
Ronco joined Hikma after 11 years with Zydus Pharmaceuticals where she most recently served as senior vice president, sales and marketing. Earlier in her career she held roles at TEVA, Sandoz, Aventis and Johnson & Johnson.
”I am thrilled to be joining Hikma’s Generics business and look forward to helping the company fulfill its vital mission of producing and distributing high-quality generic medicines that each day put better health within reach of millions of people,” Ronco said.